Xtant Medical Holdings is forecast to grow earnings and revenue by 85.5% and 15.1% per annum respectively while EPS is expected to grow by 56.4% per annum.
Key information
85.5%
Earnings growth rate
56.4%
EPS growth rate
Medical Equipment earnings growth
14.3%
Revenue growth rate
15.1%
Future return on equity
n/a
Analyst coverage
Low
Last updated
13 Nov 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:XMS - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2026
165
5
N/A
N/A
1
12/31/2025
134
-2
-2
0
2
12/31/2024
118
-11
-20
-16
2
6/30/2024
111
-3
-18
-16
N/A
3/31/2024
101
-2
-15
-13
N/A
12/31/2023
91
1
-11
-10
N/A
9/30/2023
78
3
-12
-11
N/A
6/30/2023
68
-9
-11
-9
N/A
3/31/2023
63
-8
-8
-7
N/A
12/31/2022
58
-8
-7
-5
N/A
9/30/2022
57
-9
-5
-3
N/A
6/30/2022
56
-8
-3
-1
N/A
3/31/2022
56
-7
-1
1
N/A
12/31/2021
55
-5
-2
0
N/A
9/30/2021
55
-3
-1
1
N/A
6/30/2021
56
-3
0
2
N/A
3/31/2021
51
-5
-2
0
N/A
12/31/2020
53
-7
-2
-1
N/A
9/30/2020
56
-8
-3
-2
N/A
6/30/2020
58
-8
-4
-3
N/A
3/31/2020
63
-8
-4
-3
N/A
12/31/2019
65
-8
-1
0
N/A
9/30/2019
66
-63
1
2
N/A
6/30/2019
68
-65
1
2
N/A
3/31/2019
71
-68
1
1
N/A
12/31/2018
72
-70
1
1
N/A
9/30/2018
73
-42
-1
0
N/A
6/30/2018
76
-47
0
1
N/A
3/31/2018
78
-52
N/A
-1
N/A
12/31/2017
83
-52
N/A
-1
N/A
9/30/2017
88
-29
N/A
-4
N/A
6/30/2017
91
-25
N/A
-7
N/A
3/31/2017
91
-20
N/A
-15
N/A
12/31/2016
90
-19
N/A
-14
N/A
9/30/2016
88
-3
N/A
-11
N/A
6/30/2016
82
-5
N/A
-13
N/A
3/31/2016
71
-4
N/A
-6
N/A
12/31/2015
59
-2
N/A
-9
N/A
9/30/2015
46
-17
N/A
-11
N/A
6/30/2015
37
-12
N/A
-8
N/A
3/31/2015
36
-11
N/A
-7
N/A
12/31/2014
35
-11
N/A
-7
N/A
9/30/2014
35
-11
N/A
-5
N/A
6/30/2014
34
-15
N/A
-5
N/A
3/31/2014
33
-15
N/A
-5
N/A
12/31/2013
33
-13
N/A
-5
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XMS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: XMS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: XMS is expected to become profitable in the next 3 years.
Revenue vs Market: XMS's revenue (15.1% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: XMS's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XMS's Return on Equity is forecast to be high in 3 years time